How Investors Should Play Gene-Therapy Stocks

For a few thousand people around the world, reaching the age of 20 is a landmark to dread, not to celebrate. Coping since birth with Leber Congenital Amaurosis (LCA), anyone with this genetic eye disorder who hasn’t...

Continue reading at Janus Henderson →